Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide-sensitive K+ currents in Xenopus oocytes.
Sakuta H
,
Okamoto K
,
Watanabe Y
.
???displayArticle.abstract???
1. The novel K+ channel opener, Y-26763 induced outward K+ currents in voltage-clamped follicle-enclosed Xenopus oocytes in a concentration-dependent manner with an EC50 value of 58 microM. 2. The Y-26763-induced K+ current was completely and reversibly blocked by glibenclamide (an ATP-sensitive K+ channel blocker) in a concentration-dependent manner (IC50 140 nM). Effects of several antiarrhythmic drugs on Y-26763-induced glibenclamide-sensitive K+ currents were investigated. 3. (+/-)-Cibenzoline, RS-2135, pirmenol, lorcainide and KW-3407 (class I antiarrhythmic drugs, Na+ channel blockers) suppressed Y-26763 responses in a concentration-dependent manner with IC50 values (in microM) of 6.6, 54, 68, 71 and 370, respectively. 4. Clofilium, E-4031, MS-551 and bretylium (class III antiarrhythmic drugs which increase the action potential duration) also suppressed Y-26763 responses concentration-dependently, IC50 values (in microM) were 3.3, 660, 980 and > or = 2000, respectively. N-acetylprocainamide (class III antiarrhythmic drug) scarcely suppressed Y-26763 responses. 5. The glibenclamide-sensitive K+ currents elicited by KRN2391 were also suppressed by all these antiarrhythmic drugs. 6. The antiarrhythmic drugs, clofilium and (+/-)-cibenzoline block glibenclamide-sensitive K+ channels in Xenopus oocytes at concentrations comparable to their therapeutic plasma levels.
Adaniya,
Effects of a novel class III antiarrhythmic agent, E-4031, on reentrant tachycardias in rabbit right atrium.
1990, Pubmed
Adaniya,
Effects of a novel class III antiarrhythmic agent, E-4031, on reentrant tachycardias in rabbit right atrium.
1990,
Pubmed
Ashcroft,
Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells.
,
Pubmed
Ashford,
Adenosine-5'-triphosphate-sensitive ion channels in neonatal rat cultured central neurones.
1988,
Pubmed
Bokvist,
Block of ATP-regulated and Ca2(+)-activated K+ channels in mouse pancreatic beta-cells by external tetraethylammonium and quinine.
1990,
Pubmed
Cook,
Intracellular ATP directly blocks K+ channels in pancreatic B-cells.
,
Pubmed
Dunne,
Block of ATP-regulated potassium channels by phentolamine and other alpha-adrenoceptor antagonists.
1991,
Pubmed
Earl,
Interaction of alpha adrenergic antagonists with calmodulin.
1984,
Pubmed
Escande,
The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes.
1988,
Pubmed
Haworth,
Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarrhythmic drugs.
1989,
Pubmed
Henquin,
Quinine-induced modifications of insulin release and glucose metabolism by isolated pancreatic islets.
1975,
Pubmed
Hidaka,
Naphthalenesulfonamides as calmodulin antagonists.
1983,
Pubmed
Himmel,
TMB-8 as a pharmacologic tool in guinea pig myocardial tissues. I. Effects of TMB-8 on force of contraction and on action potential parameters in atrial and papillary muscles.
1990,
Pubmed
Honoré,
Hormone-regulated K+ channels in follicle-enclosed oocytes are activated by vasorelaxing K+ channel openers and blocked by antidiabetic sulfonylureas.
1991,
Pubmed
,
Xenbase
Jeandel,
Hypoglycaemia induced by cibenzoline.
1988,
Pubmed
Kamiya,
Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia.
1992,
Pubmed
Kantor,
Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea.
1990,
Pubmed
Kozlowski,
Barbiturates inhibit ATP-K+ channels and voltage-activated currents in CRI-G1 insulin-secreting cells.
1991,
Pubmed
Kumazawa,
Synthesis and antiarrhythmic activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines.
1990,
Pubmed
Kusano,
Cholinergic and catecholaminergic receptors in the Xenopus oocyte membrane.
1982,
Pubmed
,
Xenbase
Lynch,
Therapeutic potential of modulating potassium currents in the diseased myocardium.
1992,
Pubmed
Mannhold,
Molecular pharmacological aspects of antiarrhythmic activity, II: Interaction of class I compounds with calmodulin.
1990,
Pubmed
Matsuoka,
Comparison of Ca2+ channel inhibitory effects of cibenzoline with verapamil on guinea-pig heart.
1991,
Pubmed
Müller,
Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel.
1991,
Pubmed
Nakabayashi,
Disopyramide induces insulin secretion and plasma glucose diminution: studies using the in situ canine pancreas.
1989,
Pubmed
Nakajima,
Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
1992,
Pubmed
Noack,
Characterization of potassium currents modulated by BRL 38227 in rat portal vein.
1992,
Pubmed
Noma,
ATP-regulated K+ channels in cardiac muscle.
,
Pubmed
Notsu,
Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes.
1992,
Pubmed
Oyama,
Accelerating action of quinidine on the decay phase of transient outward current in dissociated hippocampal pyramidal neurons of rats.
1992,
Pubmed
Phillips,
Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.
1986,
Pubmed
Plant,
Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells.
1990,
Pubmed
Reder,
Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibers.
1980,
Pubmed
Sakuta,
Blockade by antiarrhythmic drugs of glibenclamide-sensitive K+ channels in Xenopus oocytes.
1992,
Pubmed
,
Xenbase
Sakuta,
Inactivation of glibenclamide-sensitive K+ channels in Xenopus oocytes by various calmodulin antagonists.
1992,
Pubmed
,
Xenbase
Schulz,
An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors.
1989,
Pubmed
Semel,
Fasting hypoglycemia associated with disopyramide.
1983,
Pubmed
Silver,
Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents.
1989,
Pubmed
Spruce,
Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane.
,
Pubmed
Sturgess,
The sulphonylurea receptor may be an ATP-sensitive potassium channel.
1985,
Pubmed
Szewczyk,
TMB-8 (8-(N,N-diethylamino) octyl-3,4,5-trimethoxybenzoate) inhibits the ATP-sensitive K+ channel.
1992,
Pubmed
Weiss,
Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents.
1978,
Pubmed
Yorikane,
Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate.
1991,
Pubmed
